Gαi2 C-末端肽段靶向超声造影剂的制备及靶向性评价

Abstract
Figure/Table
References (25)
Related Citation (0)

Download: PDF (871 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the feasibility and targeting of Gαi2 C-terminal peptide (Gαi2ctp) targeted-ultrasound contrast agent. Methods The targeted microbubbles were divided into three groups of 0.5, 1.5, 3 mg/L according to the quality of Gαi2ctp. Gαi2ctp-targeted microbubbles were prepared by electrostatic attraction way, and the optimal combined dose was explored by detecting the size, carrying rate of microbubbles. The best dose was choosed for animal experiments by making a canine atrial fibrillation model. Ultrasound-targeted microbubble destruction was used to destroy the microbubbles and immunofluorescence method was used to detect the targeting of the microbubbles. Results Gαi2ctp and SonoVue microbubbles could be combined effectively by electrostatic attraction way. The Gαi2ctp targeted microbubble carrying rate of 1.5 mg/L group was higher than that of 3 mg/L group at 0.5, 1 and 2 h after standing, and the differences were highly statistically significant (all P < 0.01). There was no significant difference in the Gαi2ctp targeted microbubble carrying rate between 1.5 mg/L group and 0.5 mg/L group after 0.5 mg/L at 0.5, 1 and 2 h (P > 0.05). There was no statistically significant difference in the carrying rate of 1.5 mg/L group before and after washing (P > 0.05). After washing, the Gαi2ctp targeted microbubble carrying rate of 3 mg/L group and 0.5 mg/L group were lower than those before washing, and the differences were highly statistically significant (all P < 0.01). Frozen sections of canine left atrium and pulmnoary vein were showed that bright orange-red fluorescence expression in the left atrium and pulmnoary vein of dogs in experimental group (carrying 1.5 mg/L Gαi2ctp targeting microbubbles group), but no orange-red fluorescence was in control group (SonoVue blank group). Conclusion In this study, Gαi2ctp-targeted ultrasound contrast agent is successfully prepared. It is uniform in size, stable in nature, and specifically binded to target tissues.

Key words： Gαi2 C-terminal peptide Targeted-ultrasound contrast agent Electrostatic attraction way Ultrasound-targeted microbubble destruction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIANG Hua1 MU Yuming2 WANG Chunmei2 ZHOU Xianhui3 ZHANG Jian3

Cite this article:

JIANG Hua1 MU Yuming2 WANG Chunmei2 ZHOU Xianhui3 ZHANG Jian3. Preparation and targeted evaluation of Gαi2 C-terminal peptide targeted-ultrasound contrast agent[J]. 中国医药导报, 2021, 18(1): 9-13,21.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2021/V18/I1/9

[1] Chowdhury SM，Lee T，Bachawal SV，et al. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma [J]. J Control Release，2018，281：19-28.
[2] Xiang X，Tang Y，Leng Q，et al. Targeted gene delivery to the synovial pannus in antigen-induced arthritis by ultrasound-targeted microbubble destruction in vivo [J]. Ultrasonics，2016，65：304-314.
[3] Zhang N，Yan F，Liang X，et al. Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson’s disease therapy [J]. Theranostics，2018， 8（8）：2264-2277.
[4] Pellman J，Sheikh F. Atrial fibrillation：mechanisms，therapeutics，and future directions [J]. Compr Physiol，2015，5（2）：649-665．
[5] Aksu T，Guler TE，Mutluer FO，et al. Vagal denervation in atrial fibrillation ablation：A comprehensive review [J]. Anatol J Cardiol，2017，18（2）：142-148.
[6] Aistrup GL，Villuendas R，Ng J，et al. Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation [J]. Cardiovasc Res，2009，83（3）：481-492.
[7] Aistrap GL，Cokic I，Ng J，et al. Targeted non-viral gene-based inhibition of galphai/o-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation [J]． Heart Rhythm，2011，8（11）：1722-1729．
[8] Mu Y，Li L，Ayoufu G. Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS [J]. Ultrasonics，2009，49（8）：676-681.
[9] Xue L，Lu Y，Tang B，et al. Clinical effects of “Selective Drug” regulating vagus nerve signal pathway in vagally-mediated atrial fibrillation [J]. Med Sci Monit，2018，24：2210-2217.
[10] de Leon A，Perera R，Nittayacharn P，et al. Ultrasound contrast agents and delivery systems in cancer detection and therapy [J]. Adv Cancer Res，2018，139：57-84.
[11] 张欢，彭玉兰，王红，等.冻干法制备VEGFR2靶向超声微泡体外寻靶及显影实验[J].四川大学学报：医学版，2018，49（6）：955-959.
[12] Xing W，Wang ZG，Bing H，et al. Targeting an ultrasound contrast agent to folate receptors on ovarian cancer cells：feasibility research for ultrasonic molecular imaging of tumor cells [J]. J Ultrasound Med，2010，29（4）：609-614.
[13] Abou-Elkacem L，Bachawal SV，Willmann JK. Ultrasound molecular imaging：Moving toward clinical translation [J]. Eur J Radiol，2015，84（9）：1685-1693.
[14] 李小宇，张鹏，罗文，等.携抗MUC1单克隆抗体的超声造影剂微泡制备及体外寻靶实验[J].现代生物医学进展，2017，17（10）：1815-1817.
[15] 林海宇，付丽君，向红，等.不同时期卵巢癌移植瘤的携MMP-2抗体靶向超声造影剂诊断效能[J].中国医学影像学杂志 2018，26（7）：161-164.
[16] 倪贤伟，田新桥，赵应征，等.超声微泡介导MaFGF对阿霉素心力衰竭大鼠心功能的保护作用及其机制研究[J].心电与循环，2019，38（6）：458-462.
[17] 岳媛媛，王志刚，张萍，等.一种新型靶向微泡-干细胞复合体的制备[J].中国医学影像技术，2014，30（5）：680-684.
[18] Qian L，Thapa B，Hong J，et al. The present and future role of ultrasound-targeted microbubble destruction in preclinical studies of cardiac gene therapy [J]. J Thorac Dis，2018，10（2）：1099-1111.
[19] Chen F，Li Y，Liu Z，et al. Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma [J]. Am J Cancer Res，2019，9（10）：2278.
[20] Yang F，Li Y，Liu C，et al. Prepartion of cationic lipid-coated ultrasound contrast agents and noninvasive gene transfection Via ultrasound -targeted microbubble destruction [J]. Curr Pharm Des，2018，24（30）：3587-3595.
[21] Scimia MC，Gumpert AM，Koch WJ. Cardiovascular gene therapy for myocardial infaction [J]. Expert Opin Biol Ther，2014，14（2）：183-195.
[22] 苏高峰，穆玉明.超声及微泡介导的基因载体的进展[J].中国医药导报，2016，13（12）：36-39.
[23] Zhang D，Yang L，Tian H，et al. Enhancement of gene transfection efficiency and therapeutic effect of ultrasound-targeted microbubble destruction in vivo with cationic microbubble [J]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi，2018，32（2）：228-236.
[24] Chen S，Chen J，Huang P，et al. Myocardial regeneration in adriamycin cardiomyopathy by nuclear expression of GLP1 using ultrasound-targeted microbubbledestruction [J]. Biochem Biophy Res Commun，2015，458（4）：823-829.
[25] 迟婷婷，滕银燕，孙玮明，等.超声微泡靶向递送MaFGF改善糖尿病心肌病大鼠左心室收缩功能的初步实验研究[J].浙江医学，2019，41（24）：2576-2587.